the full WP markdown article
Eli Lilly Crushes Q4 2025 Earnings With Massive Zepbound Boost
Eli Lilly just dropped their Q4 2025 earnings, and the numbers are staggering – revenue way above expectations thanks to Zepbound and Mounjaro. But what does the strong 2026 guidance really mean for investors, and is the GLP-1 boom here to stay? ...
Financial market analysis from 04/02/2026. Market conditions may have changed since publication.
❝
The single most powerful asset we all have is our mind. If it is trained well, it can create enormous wealth in what seems to be an instant.
— Robert Kiyosaki
Author
Steven Soarez passionately shares his financial expertise to help everyone better understand and master investing. Contact us for collaboration opportunities or sponsored article inquiries.
Previous
AMD Stock Drops 9% Post-Earnings: What Really Happened
Next
Sheryl Sandberg Backs AI Workplace Startup Slashwork
Related Articles
Crypto
UK Crypto Firms Face New FCA Authorization Rules
UK crypto firms just learned that old registrations will not carry over. Applications open soon, yet one February deadline could decide who keeps operating when the new regime starts.
Sep 17, 2026
11 min read
Crypto
XRP Eyes $2 Breakout While BlockchainFX Presale Hits $14.37M Milestone
XRP hovers near $1.43 with $2 on the horizon as spot buyers absorb dips, but one presale quietly raised over $14 million with daily rewards and a 60% bonus. Is this the smarter play before the next big move?
Apr 27, 2026
9 min read
Market News
COVID Skeptics Vindicated: Lessons From Years of Debate
What if everything you were told to dismiss as conspiracy turned out to be closer to reality? Bret Weinstein reflects on a hard-won battle for truth in the COVID era and why victory feels hollow despite the evidence. The full story raises tough questions about accountability.
Aug 1, 2026
9 min read